{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T21:33:19Z","timestamp":1757539999934},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Gansu Provincial Science and Technology Plan","award":["23JRRA0929","22JR5RA901","22JR11RA022"],"award-info":[{"award-number":["23JRRA0929","22JR5RA901","22JR11RA022"]}]},{"name":"Lanzhou Science and Technology Plan Project","award":["2022-3-45","2023-2-38"],"award-info":[{"award-number":["2022-3-45","2023-2-38"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82360510","82260555"],"award-info":[{"award-number":["82360510","82260555"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Intra-Hospital Fund of the First Hospital of Lanzhou University","award":["ldyyyn2022-12"],"award-info":[{"award-number":["ldyyyn2022-12"]}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"crossref","award":["23JRRA1601"],"award-info":[{"award-number":["23JRRA1601"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Chengguan District Science and Technology Plan","award":["2023SHFZ0018"],"award-info":[{"award-number":["2023SHFZ0018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-72830-0","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T16:05:55Z","timestamp":1726243555000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Establishment and characterization of a novel human gallbladder cancer cell line, GBC-X1"],"prefix":"10.1038","volume":"14","author":[{"given":"Changpeng","family":"Chai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanhui","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wence","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,13]]},"reference":[{"key":"72830_CR1","doi-asserted-by":"publisher","unstructured":"Siegel, R. L., Miller, K. D., Jemal, A. & Cancer statistics CA Cancer J Clin. 70, 7\u201330. (2020). https:\/\/doi.org\/10.3322\/caac.21590 (2020).","DOI":"10.3322\/caac.21590"},{"key":"72830_CR2","unstructured":"Menon, G. & Babiker, H. M. Gallbladder carcinoma. in StatPearls (StatPearls Publishing, Treasure Island, FL, 2024)."},{"key":"72830_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"72830_CR4","doi-asserted-by":"publisher","unstructured":"Song, X. et al. Overview of current targeted therapy in gallbladder cancer. Signal Transduct Target Ther. 5, 230. (2020). https:\/\/doi.org\/10.1038\/s41392-020-00324-2 (2020).","DOI":"10.1038\/s41392-020-00324-2"},{"key":"72830_CR5","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1002\/ijc.32863","volume":"147","author":"A Miranda-Filho","year":"2020","unstructured":"Miranda-Filho, A. et al. Gallbladder and extrahepatic bile duct cancers in the Americas: incidence and mortality patterns and trends. Int. J. Cancer. 147, 978\u2013989. https:\/\/doi.org\/10.1002\/ijc.32863 (2020).","journal-title":"Int. J. Cancer"},{"key":"72830_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.21037\/cco.2019.08.13","volume":"8","author":"MA Schmidt","year":"2019","unstructured":"Schmidt, M. A., Marcano-Bonilla, L. & Roberts, L. R. Gallbladder cancer: epidemiology and genetic risk associations. Chin. Clin. Oncol.8, 31. https:\/\/doi.org\/10.21037\/cco.2019.08.13 (2019).","journal-title":"Chin. Clin. Oncol."},{"key":"72830_CR7","doi-asserted-by":"publisher","unstructured":"Tuo, J. Y. et al. Report of incidence and mortality of gallbladder cancer in China, Zhonghua zhong liu za zhi [Chinese journal of oncology], 40, 894\u2013899. (2014). https:\/\/doi.org\/10.3760\/cma.j.issn.0253-3766.2018.12.004 (2018).","DOI":"10.3760\/cma.j.issn.0253-3766.2018.12.004"},{"key":"72830_CR8","first-page":"4","volume":"41","author":"YS Li","year":"2021","unstructured":"Li, Y. S., Li, M. L. & Liu, Y. B. Current status and future prospects of basic research on gallbladder carcinoma. Chin. J. Practical Surg.41, 4 (2021).","journal-title":"Chin. J. Practical Surg."},{"key":"72830_CR9","doi-asserted-by":"publisher","first-page":"101936","DOI":"10.1016\/j.ctrv.2019.101936","volume":"84","author":"A Lamarca","year":"2020","unstructured":"Lamarca, A. et al. Current standards and future perspectives in adjuvant treatment for biliary tract cancers. Cancer Treat. Rev.84, 101936. https:\/\/doi.org\/10.1016\/j.ctrv.2019.101936 (2020).","journal-title":"Cancer Treat. Rev."},{"key":"72830_CR10","doi-asserted-by":"publisher","first-page":"e678","DOI":"10.1002\/ctm2.678","volume":"12","author":"B Yuan","year":"2022","unstructured":"Yuan, B. et al. Patient-derived organoids for personalized gallbladder cancer modelling and drug screening. Clin. Transl Med.12, e678. https:\/\/doi.org\/10.1002\/ctm2.678 (2022).","journal-title":"Clin. Transl Med."},{"key":"72830_CR11","doi-asserted-by":"publisher","first-page":"695","DOI":"10.14218\/JCTH.2022.00351","volume":"11","author":"J Xing","year":"2023","unstructured":"Xing, J. et al. Application and progress of cultured models of Gallbladder Carcinoma. J. Clin. Transl Hepatol.11, 695\u2013704. https:\/\/doi.org\/10.14218\/JCTH.2022.00351 (2023).","journal-title":"J. Clin. Transl Hepatol."},{"key":"72830_CR12","first-page":"574","volume":"71","author":"S Koyama","year":"1980","unstructured":"Koyama, S. et al. Establishment of a cell line (G-415) from a human gallbladder carcinoma. Gan. 71, 574\u2013575 (1980).","journal-title":"Gan"},{"key":"72830_CR13","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.3390\/cancers11081098","volume":"11","author":"P Mirabelli","year":"2019","unstructured":"Mirabelli, P., Coppola, L. & Salvatore, M. Cancer Cell lines are useful Model systems for Medical Research. Cancers (Basel).  11, 1098. https:\/\/doi.org\/10.3390\/cancers11081098 (2019).","journal-title":"Cancers (Basel)"},{"key":"72830_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12859-023-05133-2","volume":"24","author":"L Guo","year":"2023","unstructured":"Guo, L. et al. GBCdb: RNA expression landscapes and ncRNA-mRNA interactions in gallbladder carcinoma. BMC Bioinform.24, 12. https:\/\/doi.org\/10.1186\/s12859-023-05133-2 (2023).","journal-title":"BMC Bioinform."},{"key":"72830_CR15","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1136\/gutjnl-2014-308252","volume":"64","author":"SJ Lin","year":"2015","unstructured":"Lin, S. J. et al. Signatures of tumour immunity distinguish Asian and non-asian gastric adenocarcinomas. Gut. 64, 1721\u20131731. https:\/\/doi.org\/10.1136\/gutjnl-2014-308252 (2015).","journal-title":"Gut"},{"key":"72830_CR16","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/jso.24835","volume":"117","author":"I Nassour","year":"2018","unstructured":"Nassour, I. et al. Racial and ethnic disparities in a national cohort of ampullary cancer patients. J. Surg. Oncol.117, 220\u2013227. https:\/\/doi.org\/10.1002\/jso.24835 (2018).","journal-title":"J. Surg. Oncol."},{"key":"72830_CR17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3390\/cells8020157","volume":"8","author":"E Hattori","year":"2019","unstructured":"Hattori, E., Oyama, R. & Kondo, T. Systematic review of the current status of human sarcoma cell lines. Cells. 8, 157. https:\/\/doi.org\/10.3390\/cells8020157 (2019).","journal-title":"Cells"},{"key":"72830_CR18","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.3748\/wjg.v29.i17.2642","volume":"29","author":"H Xu","year":"2023","unstructured":"Xu, H. et al. Establishment and characterization of a new human ampullary carcinoma cell line, DPC-X1. World J. Gastroenterol.29, 2642\u20132656. https:\/\/doi.org\/10.3748\/wjg.v29.i17.2642 (2023).","journal-title":"World J. Gastroenterol."},{"key":"72830_CR19","first-page":"113","volume":"46","author":"RM Sutherland","year":"1971","unstructured":"Sutherland, R. M., McCredie, J. A. & Inch, W. R. Growth of multicell spheroids in tissue culture as a model of nodular carcinomas. J. Natl. Cancer Inst.46, 113\u2013120 (1971).","journal-title":"J. Natl. Cancer Inst."},{"key":"72830_CR20","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.gde.2007.05.002","volume":"17","author":"MS Steinberg","year":"2007","unstructured":"Steinberg, M. S. Differential adhesion in morphogenesis: a modern view. Curr. Opin. Genet. Dev.17, 281\u2013286. https:\/\/doi.org\/10.1016\/j.gde.2007.05.002 (2007).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"72830_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/s1040-8428(00)00077-9","volume":"36","author":"RC Bates","year":"2000","unstructured":"Bates, R. C., Edwards, N. S. & Yates, J. D. Spheroids and cell survival. Crit. Rev. Oncol. Hematol.36, 61\u201374. https:\/\/doi.org\/10.1016\/s1040-8428(00)00077-9 (2000).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"72830_CR22","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3390\/cancers13040874","volume":"13","author":"S Gunti","year":"2021","unstructured":"Gunti, S., Hoke, A. T. K., Vu, K. P. & London, N. R. Jr Organoid and Spheroid Tumor models: techniques and applications. Cancers.  13, 874. https:\/\/doi.org\/10.3390\/cancers13040874 (2021).","journal-title":"Cancers"},{"key":"72830_CR23","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.pharmthera.2016.03.013","volume":"163","author":"S Nath","year":"2016","unstructured":"Nath, S. & Devi, G. R. Three-dimensional culture systems in cancer research: focus on tumor spheroid model. Pharmacol. Ther.163, 94\u2013108. https:\/\/doi.org\/10.1016\/j.pharmthera.2016.03.013 (2016).","journal-title":"Pharmacol. Ther."},{"key":"72830_CR24","doi-asserted-by":"publisher","first-page":"5780","DOI":"10.3390\/ijms22115780","volume":"22","author":"Y Takahashi","year":"2021","unstructured":"Takahashi, Y. et al. Application of immunohistochemistry in the pathological diagnosis of liver tumors. Int. J. Mol. Sci.22, 5780. https:\/\/doi.org\/10.3390\/ijms22115780 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"72830_CR25","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1074\/mcp.M500279-MCP200","volume":"4","author":"M Uhl\u00e9n","year":"2005","unstructured":"Uhl\u00e9n, M. et al. A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol. Cell. Proteom.4, 1920\u20131932. https:\/\/doi.org\/10.1074\/mcp.M500279-MCP200 (2005).","journal-title":"Mol. Cell. Proteom."},{"key":"72830_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4251\/wjgo.v3.i4.49","volume":"3","author":"G Malaguarnera","year":"2011","unstructured":"Malaguarnera, G. et al. Markers of bile duct tumors. World J. Gastrointest. Oncol.3, 49\u201359. https:\/\/doi.org\/10.4251\/wjgo.v3.i4.49 (2011).","journal-title":"World J. Gastrointest. Oncol."},{"key":"72830_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto, M. A., Huang, R. Y., Jackson, R. A. & Thiery, J. P. EMT: 2016 Cell.166, 21\u201345. https:\/\/doi.org\/10.1016\/j.cell.2016.06.028 (2016).","journal-title":"EMT: 2016 Cell."},{"key":"72830_CR28","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","volume":"29","author":"I Pastushenko","year":"2019","unstructured":"Pastushenko, I. & Blanpain, C. E. M. T. Transition States during Tumor Progression and Metastasis. Trends Cell Biol.29, 212\u2013226. https:\/\/doi.org\/10.1016\/j.tcb.2018.12.001 (2019).","journal-title":"Trends Cell Biol."},{"key":"72830_CR29","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.tcb.2020.07.003","volume":"30","author":"B Bakir","year":"2020","unstructured":"Bakir, B., Chiarella, A. M., Pitarresi, J. R., Rustgi, A. K. & EMT MET, plasticity, and Tumor Metastasis. Trends Cell. Biol.30, 764\u2013776. https:\/\/doi.org\/10.1016\/j.tcb.2020.07.003 (2020).","journal-title":"Trends Cell. Biol."},{"key":"72830_CR30","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.ceb.2006.10.002","volume":"18","author":"BA Weaver","year":"2006","unstructured":"Weaver, B. A. & Cleveland, D. W. Does aneuploidy cause cancer? Curr. Opin. Cell. Biol.18, 658\u2013667. https:\/\/doi.org\/10.1016\/j.ceb.2006.10.002 (2006).","journal-title":"Curr. Opin. Cell. Biol."},{"key":"72830_CR31","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/s41467-024-45265-4","volume":"15","author":"R Xiao","year":"2024","unstructured":"Xiao, R. et al. Aneuploid embryonic stem cells drive teratoma metastasis. Nat. Commun.15, 1087. https:\/\/doi.org\/10.1038\/s41467-024-45265-4 (2024).","journal-title":"Nat. Commun."},{"key":"72830_CR32","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.ccell.2018.03.007","volume":"33","author":"AM Taylor","year":"2018","unstructured":"Taylor, A. M. et al. Genomic and functional approaches to understanding Cancer Aneuploidy. Cancer Cell.33, 676\u2013689e3. https:\/\/doi.org\/10.1016\/j.ccell.2018.03.007 (2018).","journal-title":"Cancer Cell."},{"key":"72830_CR33","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1186\/s12885-019-5850-7","volume":"19","author":"Y Chen","year":"2019","unstructured":"Chen, Y., Yang, Z., Wang, Y., Wang, J. & Wang, C. Karyotyping of circulating tumor cells for predicting chemotherapeutic sensitivity and efficacy in patients with esophageal cancer. BMC cancer. 19, 651. https:\/\/doi.org\/10.1186\/s12885-019-5850-7 (2019).","journal-title":"BMC cancer"},{"key":"72830_CR34","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1007\/s00432-019-03040-9","volume":"145","author":"Y Wang","year":"2019","unstructured":"Wang, Y. et al. Vimentin expression in circulating tumor cells (CTCs) associated with liver metastases predicts poor progression-free survival in patients with advanced lung cancer. J. Cancer Res. Clin. Oncol.145, 2911\u20132920. https:\/\/doi.org\/10.1007\/s00432-019-03040-9 (2019).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"72830_CR35","doi-asserted-by":"publisher","first-page":"6609","DOI":"10.2147\/IJGM.S330361","volume":"14","author":"M Huang","year":"2021","unstructured":"Huang, M. et al. Aneuploid Circulating Tumor Cells as a predictor of response to Neoadjuvant Chemotherapy in Non-small Cell Lung Cancer. Int. J. Gen. Med.14, 6609\u20136620. https:\/\/doi.org\/10.2147\/IJGM.S330361 (2021).","journal-title":"Int. J. Gen. Med."},{"key":"72830_CR36","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1136\/jcp.50.7.591","volume":"50","author":"AE Pinto","year":"1997","unstructured":"Pinto, A. E., Andr\u00e9, S., Nogueira, M., Mendon\u00e7a, E. & Soares, J. Flow cytometric DNA hypertetraploidy is associated with unfavourable prognostic features in breast cancer. J. Clin. Pathol.50, 591\u2013595. https:\/\/doi.org\/10.1136\/jcp.50.7.591 (1997).","journal-title":"J. Clin. Pathol."},{"key":"72830_CR37","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00428-014-1694-3","volume":"466","author":"J Bezi\u0107","year":"2015","unstructured":"Bezi\u0107, J. et al. Flow cytometric DNA hypertetraploidy tends to be more frequent in male than in female breast cancers. Virchows Arch.466, 185\u2013189. https:\/\/doi.org\/10.1007\/s00428-014-1694-3 (2015).","journal-title":"Virchows Arch."},{"key":"72830_CR38","first-page":"184","volume":"5","author":"K Bjelkenkrantz","year":"1983","unstructured":"Bjelkenkrantz, K., Lundgren, J. & Olofsson, J. Single-cell DNA measurement in hyperplastic, dysplastic and carcinomatous laryngeal epithelia, with special reference to the occurrence of hypertetraploid cell nuclei. Anal. Quant. Cytol.5, 184\u2013188 (1983).","journal-title":"Anal. Quant. Cytol."},{"key":"72830_CR39","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41571-022-00721-2","volume":"20","author":"J Chuprin","year":"2023","unstructured":"Chuprin, J. et al. Humanized mouse models for immuno-oncology research. Nat. Rev. Clin. Oncol.20, 192\u2013206. https:\/\/doi.org\/10.1038\/s41571-022-00721-2 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"72830_CR40","doi-asserted-by":"publisher","unstructured":"Massa, A. et al. Evolution of the Experimental Models of Cholangiocarcinoma. Cancers 12, 2308. (2020). https:\/\/doi.org\/10.3390\/cancers12082308","DOI":"10.3390\/cancers12082308"},{"issue":"7","key":"72830_CR41","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1101\/pdb.top073585","volume":"2014","author":"LD Shultz","year":"2014","unstructured":"Shultz, L. D. et al. Human cancer growth and therapy in immunodeficient mouse models. Cold Spring Harb Protoc.2014 (7), 694\u2013708 (2014).","journal-title":"Cold Spring Harb Protoc."},{"key":"72830_CR42","doi-asserted-by":"publisher","unstructured":"Shultz, L. D. et al. Human cancer growth and therapy in immunodeficient mouse models. Cold Spring Harb Protoc. 694\u2013708. (2014). https:\/\/doi.org\/10.1101\/pdb.top073585 (2014).","DOI":"10.1101\/pdb.top073585"},{"key":"72830_CR43","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrd1287","volume":"3","author":"J Graham","year":"2004","unstructured":"Graham, J., Mushin, M., Kirkpatrick, P. & Oxaliplatin Nat. Rev. Drug Discov3, 11\u201312. https:\/\/doi.org\/10.1038\/nrd1287 (2004).","journal-title":"Nat. Rev. Drug Discov"},{"key":"72830_CR44","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3390\/genes13030466","volume":"13","author":"B Pandit","year":"2022","unstructured":"Pandit, B. & Royzen, M. Recent development of Prodrugs of Gemcitabine. Genes. 13, 466. https:\/\/doi.org\/10.3390\/genes13030466 (2022).","journal-title":"Genes"},{"key":"72830_CR45","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrc1074","volume":"3","author":"DB Longley","year":"2003","unstructured":"Longley, D. B., Harkin, D. P. & Johnston, P. G. 5-fluorouracil: mechanisms of action and clinical strategies. Nat. Rev. Cancer.  3, 330\u2013338. https:\/\/doi.org\/10.1038\/nrc1074 (2003).","journal-title":"Nat. Rev. Cancer"},{"key":"72830_CR46","doi-asserted-by":"publisher","first-page":"4934","DOI":"10.1021\/acs.chemrev.2c00763","volume":"123","author":"L Min","year":"2023","unstructured":"Min, L. et al. Strategies and lessons learned from total synthesis of Taxol. Chem. Rev.123, 4934\u20134971. https:\/\/doi.org\/10.1021\/acs.chemrev.2c00763 (2023).","journal-title":"Chem. Rev."},{"key":"72830_CR47","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1016\/S0007-4551(15)31220-0","volume":"102","author":"R Cohen","year":"2015","unstructured":"Cohen, R. et al. Statuts MMR et BRAF dans les cancers colorectaux: int\u00e9r\u00eats pour la prise en charge th\u00e9rapeutique? [DNA mismatch repair and BRAF status in colorectal cancer: interest for the therapeutic management?]. Bull. Cancer. 102, S72\u2013S81. https:\/\/doi.org\/10.1016\/S0007-4551(15)31220-0 (2015).","journal-title":"Bull. Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72830-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72830-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72830-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T16:21:13Z","timestamp":1726244473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72830-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,13]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["72830"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-72830-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,13]]},"assertion":[{"value":"13 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We have obtained consents to publish this paper from all the participants of this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of Lanzhou University Second Hospital (2023\u00a0A-381). Informed consent was obtained from the patient. The animal procedures were approved by the Medical Animal Experiment Ethics Committee of Lanzhou University Second Hospital (D2023-318).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"21439"}}